Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Datalex and SpaceandPeople extend deals

Thu, 13th Apr 2023 10:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Datalex PLC - Dublin-based software company in digital commerce for travel retail - Strikes three-year deal renewal with Air China Ltd, bolstering firm's position in Asia Pacific region. "As part of the renewal, Air China will migrate to the latest version of Datalex's China shopping and pricing product, which brings greater efficiencies to the airline such as improved speed to market of new features and releases. As well as achieving ongoing cost and time savings from operational efficiencies, this future-proofed product provides Air China with greater tactical flexibility and a faster market reaction time, and more choice for the airline's customers," Datalex says.

----------

SpaceandPeople PLC - retail, promotional and brand experience specialist - Extends commercialisation agreement with Network Rail Ltd. Deal is for supply of exhibitions, events and distribution activity until September 30. "This will mean that our relationship with Network Rail will continue during the anticipated tender process for a new agreement," SpaceandPeople adds. "The agreement continues to cover Network Rail's portfolio of major London and regional railway stations as well as Victoria Place Shopping Centre in London, providing access to many of the highest footfall venues in the United Kingdom."

----------

LendInvest PLC - London-based non-bank mortgage lender - Expects results for year ended March 31 in line with expectations. Says platform assets under management rise 21% on-year to GBP2.59 billion at March 31, up 6.4% from half-year. Funds under management up 45% yearly to GBP3.61 billion, up 4.8% from half-year level. "We have continued to deliver on the commitments we laid out at our IPO. We are growing and optimising our FuM accessing strong demand from some of the world's largest and most sophisticated financial institutions. We are expanding our Platform AuM and we are continuing to invest in our technology platform to further strengthen our competitive advantage as a technology-driven lending and funding platform for mortgages," Chief Executive Officer Rod Lockhart says.

----------

Avation PLC - aircraft leasing firm - Sells 10-year old ATR 72-600 aircraft at a price above book value. Reduces firm's off-lease aircraft inventory to just one aircraft. "This aircraft has been off-lease since its redelivery from Virgin Australia in 2020. Avation's technical team has managed the storage and now major maintenance checks required to deliver the aircraft into commercial operation," aviation says.

----------

Vp PLC - equipment rental company - Hails "good progress" in core markets of housebuilding, construction, infrastructure and energy. Expects results for full-year ended March in line with board expectations. "The UK division has continued to make good progress and has seen the benefit of a stronger civil engineering and infrastructure market. Whilst general construction sector demand shows some level of volatility it is stable overall, though the group has seen some regional market weakness in the South East of England in recent months. Whilst our housebuilding customer base has, as anticipated, reduced volumes since the start of the new calendar year, the position is stable for Vp and the group remains busy in that sector," Vp adds. Says in UK arm, it has "successfully negotiated price increases" with customers to fight inflationary pressure.

----------

Literacy Capital PLC - investment trust focused on opportunities to invest for the long-term in growing private UK businesses - Acquires minority stake in Cadro Technologies Ltd, a wealth and investment management company. "Headquartered in London, Cadro combines wealth and investment management services with powerful new technology, providing private clients and institutions with a more modern experience and better outcomes," Literacy Capital adds. "Literacy Capital is investing to support and accelerate the growth of the business. Many wealth and investment managers are highly traditional and have not adapted to cater to the needs of modern high-net-worth individuals and institutions. The Cadro team has a proven track record of managing these types of clients and their investments, and a strong awareness of the evolving needs of the industry."

----------

Angle PLC - medical diagnostics company - Signs pharma services pact with Crescendo Biologics Ltd, a new customer. Crescendo is a clinical stage immuno-oncology company. It will use Angle's Portrait Flex assay in an ongoing Phase 1 clinical trial.

----------

Synergia Energy Ltd - developer of natural gas assets in India - Jet pump artificial lift equipment for the C-77H well in Cambay on schedule to be delivered in late May to early June. "The jet pump equipment will have sufficient capacity to lift not only the fluids from the two currently producing re-frac zones, but also the fluids associated with the original four fracked zones that are currently isolated with a bridge plug. Consequently the Company plans to remove the bridge plug and re-connect the four original zones when the well is re-completed with the jet pump artificial lift system," Synergia says. Says two producing C-77H re-frac zone producing on plateau at 150,000 standard cubic feet per day. "The company anticipates that production from these two zones will be enhanced by the jet pump installation and this enhanced production will be further increased by the contribution of the re-connected original four zones in the C-77H well," it adds. Says farm-out talks for Cambay ongoing, unaffected by lift implementation.

----------

Savannah Energy PLC - energy company, with projects in Cameroon, Chad, Niger and Nigeria- Revenue in first quarter grows 26% on-year to USD147.6 million. "This morning's update clearly demonstrates the strength and potential of our business and the positive impact we are making in our host countries," CEO Andrew Knott says.

----------

Castillo Copper Ltd - base metal explorer primarily focused on copper across Australia and Zambia - Appoints Australian Nuclear Science & Technology Organisation to perform metallurgical test-work on six samples taken from BHA project. "This is an important step towards advancing the viability of the BHA project's east zone rare earth elements potential and securing interest from prospective development partners," Castillo says.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Aug 2019 10:57

Angle Ovarian Cancer Testing Platform Study Enrols First Patients

(Alliance News) - Liquid biopsy firm Angle PLC said Thursday the first patients for its ovarian cancer test study have been enrolled ahead of anticipated completion early in 2020.The study

Read more
29 Aug 2019 09:12

Angle initiates main phase of ovarian cancer clinical study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the main phase of its 200-patient ovarian cancer clinical verification study has been initiated and the first patient has been enrolled.

Read more
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
21 Jun 2019 15:26

Angle upbeat on recent cancer research results

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the University Medical Centre Hamburg-Eppendorf (UKE) cancer centre has published results of work demonstrating that its 'Parsortix' system can be used as a liquid biopsy to investigate programmed death-ligand 1 (PD-L1) status in non small cell lung cancer (NSCLC) patients.

Read more
21 Jun 2019 12:56

Angle's Parsortix Successfully Investigates Immunotherapy Target

(Alliance News) - Angle PLC on Friday said its Parsortix system has been successfully used as a liquid biopsy to investigate an immunotherapy target in lung cancer.Shares in Angle were up a

Read more
5 Jun 2019 13:04

Angle's Parsortix And HyCEAD Ziplex Systems Identify Cancer In Study

LONDON (Alliance News) - Angle PLC on Wednesday announced positive results from a study evaluating the ability of its Parsortix and HyCEAD Ziplex platforms to test for ovarian cancer.The to

Read more
31 May 2019 09:53

Angle reveals positive results from latest Parsortix study

(Sharecast News) - Liquid biopsy company Angle announced positive results from its 'Parsortix' FDA clinical study for metastatic breast cancer on Friday.

Read more
26 Apr 2019 12:48

Angle's Parsortix system used in more groundbreaking research

(Sharecast News) - Liquid biopsy company Angle announced on Friday that its 'Parsortix' system has been utilised in further groundbreaking new cancer research, demonstrating the role of myeloid-derived suppressor cells (MDSCs) as part of large circulating tumor cell (CTC) clusters, which are 50x more likely to generate metastasis than single CTCs, for the first time.

Read more
26 Apr 2019 12:29

Angle's Parsortix System Used In Further "Groundbreaking" Research

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said its Parsortix system has been used in "groundbreaking" cancer research.The research showed the first the time

Read more
18 Apr 2019 11:35

US Cancer Centre Uses Angle's Parsortix System For Assessments

LONDON (Alliance News) - Angle PLC on Thursday said its ParsortixTM system was used by the University of Texas MD Anderson Cancer Center to develop a new technique for assessing the metastatic of

Read more
12 Apr 2019 15:25

Angle's Parsortix to be used in new Greece study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that a leading customer has established a multi-centre study to investigate biomarkers on circulating tumor cells (CTCs), using its 'Parsortix' system, which could give advance warning of relapse in non small cell lung cancer (NSCLC).

Read more
12 Apr 2019 11:59

University Of Athens Cancer Study To Use Angle's Parsortix System

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said a "leading" customer has set up a multi-centre study using its Parsortix system.The study is being carried out

Read more
7 Mar 2019 13:09

Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix

LONDON (Alliance News) - Angle PLC on Thursday said it has completed enrolment for a US study of its Parsortix biopsy technology in metastatic breast cancer.All of the 400 subjects required

Read more
7 Mar 2019 09:35

Angle completes enrolment in Parsortix breast cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cancer was now complete.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.